STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News:
Karo Bio (STO:KARO)
Eprotirome (new generic name for KB2115) is a new compound that lowers high blood lipid levels by activating the thyroid hormone receptor in the liver. Data from the first two week study in 24 patients with elevated cholesterol levels have now been published in PNAS with the title “The thyroid hormone mimetic compound KB2115 lowers plasma low density protein (LDL) cholesterol without cardiac effects in man”.
